About Us

Guardant Health AMEA is a wholly owned subsidiary of Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.

Solutions

We are dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood tests and the data they unlock. Today our tests help inform treatment decisions for patients with advanced cancer. Our tests also detect residual and recurrent disease for patients with early-stage cancer and will soon screen to find cancer at its earliest and most treatable.

Guardant 360 image
0
+
Clinical Samples Reported
0
+
Biopharma Partners
0
+
Ordering Oncologists
0
+
Peer-reviewed publications

Ordering Process

order icon

Physician to request a kit online or contact our local partner

blood donation icon

Blood/Tissue samples to be taken from the patient

email icon

Kit to be stored at room temperature and couriered to the laboratory

7 days icon

Test report to be emailed to physician

News & Events

Guardant Health supports Prostate Cancer Awareness Month
LinkedIn
September marks Prostate Cancer Awareness Month. Check out this study (https://jitc.bmj.com/content/8/2/e001065) which concluded that the use of a well-validated cfDNA NGS liquid biopsy…
Guardant Health @ ESMO 2022: Visit us at Booth #426
LinkedIn
Come and talk to us at booth #426 if you are in Paris for the European Society for Medical Oncology (ESMO) Congress 2022,…
Guardant Health AMEA wins Precision Oncology Provider of the Year in Asia-Pacific 2022
LinkedIn
Our CEO, Simranjit Singh, recently received an award on behalf of Guardant Health AMEA for being the Precision Oncology Provider of the Year in…

Where to Find Us

Search Location

Category

Distance Range Radius: KM

Status

Get Your Directions

Show Distance In

Use my location to find the closest Service Provider near me

Number of Countries: 0
Loading...

Directions

Message us